Home/Filings/4/0001225208-19-005066
4//SEC Filing

Currarino Moyano Giancarlo 4

Accession 0001225208-19-005066

CIK 0000812074other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 7:16 PM ET

Size

23.0 KB

Accession

0001225208-19-005066

Insider Transaction Report

Form 4
Period: 2019-03-07
Currarino Moyano Giancarlo
SVP, Chief Tech & SC Officer
Transactions
  • Award

    Common Stock (Direct)

    2019-03-07+12,26475,772 total
  • Sale

    Common Stock (Direct)

    2019-03-07$19.74/sh9,371$185,02977,430 total
  • Sale

    Common Stock (Direct)

    2019-03-07$20.10/sh11,295$226,99166,135 total
  • Exercise/Conversion

    Common Stock (Direct)

    2019-03-07$17.78/sh+1,104$19,62988,171 total
  • Sale

    Common Stock (Direct)

    2019-03-07$20.10/sh1,104$22,18786,801 total
  • Exercise/Conversion

    Stock Option 03/07/2016 $15.05

    2019-03-0711,2955,647 total
    Exercise: $15.05From: 2017-03-07Exp: 2023-03-07Common Stock (Direct) (11,295 underlying)
  • Award

    Common Stock (Direct)

    2019-03-07+35,52463,508 total
  • Sale

    Common Stock (Direct)

    2019-03-07$20.10/sh266$5,34687,905 total
  • Exercise/Conversion

    Common Stock (Direct)

    2019-03-07$15.05/sh+11,295$169,99087,067 total
  • Sale

    Common Stock (Direct)

    2019-03-07$19.52/sh35,524$693,48230,611 total
  • Exercise/Conversion

    Stock Option 09/01/16 $17.78

    2019-03-071,1042,208 total
    Exercise: $17.78From: 2017-09-01Exp: 2023-09-01Common Stock (Direct) (1,104 underlying)
Holdings
  • Common Stock (Indirect)

    (indirect: By 401(k))
    898.416
Footnotes (7)
  • [F1]Certain restricted stock units granted for the 2016-2018 grant period vest in the form of common stock based upon the Issuer's performance against certain strategic objective goals. On March 7, 2019, the Compensation Committee of the Issuer's Board of Directors determined that the strategic objective goals had been met, resulting in the vesting of these shares.
  • [F2]The restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.89 to $20.24, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.70 to $19.895, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.44 to $19.64, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F6]The options become exercisable in annual 25% increments beginning on the first anniversary of the grant date, March 7, 2017.
  • [F7]The options become exercisable in annual 25% increments beginning on the first anniversary of the grant date, September 1, 2017.

Documents

1 file

Issuer

OWENS ILLINOIS INC /DE/

CIK 0000812074

Entity typeother

Related Parties

1
  • filerCIK 0001706289

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 7:16 PM ET
Size
23.0 KB